OBJECTIVE: To assess whether a platelet-rich plasma (PRP) injection leads to an enhanced tendon structure and neovascularisation, measured with ultrasonographic techniques, in chronic midportion Achilles tendinopathy. DESIGN: Double-blind, randomised, placebo-controlled clinical trial. SETTING:Sports medical department of The Hague medical centre. PATIENTS: 54 patients with chronic midportion Achilles tendinopathy were included. INTERVENTIONS: Patients were randomised to eccentric exercise therapy with either a PRP injection (PRP group) or a saline injection (placebo group). MAIN OUTCOME MEASUREMENTS: Tendon structure was evaluated by ultrasonographic tissue characterisation, a novel technique which quantifies tendon structure into four echo-types: echo-types I+II represent organised tendon bundles, whereas echo-types III+IV represent a disorganised tendon structure. Colour Doppler ultrasonography was used to measure the degree of neovascularisation. Follow-up was at 6, 12 and 24 weeks. RESULTS: A significant improvement in echo-types I+II was found after 24 weeks within both the PRP group (n=27) and the placebo group (n=27), but there was no significant between-group difference (95% CI -1.6 to 7.8, p=0.169). After 6 weeks, the neovascularisation score increased within the PRP group (p=0.001) and the placebo group (p=0.002), but there was no significant between-group difference in change in neovascularisation score at any point in time. CONCLUSION: Injecting PRP for the treatment of chronic midportion Achilles tendinopathy does not contribute to an increased tendon structure or alter the degree of neovascularisation, compared with placebo. FUNDING: Biomet Biologics LLC, Warsaw, Indiana.
RCT Entities:
OBJECTIVE: To assess whether a platelet-rich plasma (PRP) injection leads to an enhanced tendon structure and neovascularisation, measured with ultrasonographic techniques, in chronic midportion Achilles tendinopathy. DESIGN: Double-blind, randomised, placebo-controlled clinical trial. SETTING: Sports medical department of The Hague medical centre. PATIENTS: 54 patients with chronic midportion Achilles tendinopathy were included. INTERVENTIONS:Patients were randomised to eccentric exercise therapy with either a PRP injection (PRP group) or a saline injection (placebo group). MAIN OUTCOME MEASUREMENTS: Tendon structure was evaluated by ultrasonographic tissue characterisation, a novel technique which quantifies tendon structure into four echo-types: echo-types I+II represent organised tendon bundles, whereas echo-types III+IV represent a disorganised tendon structure. Colour Doppler ultrasonography was used to measure the degree of neovascularisation. Follow-up was at 6, 12 and 24 weeks. RESULTS: A significant improvement in echo-types I+II was found after 24 weeks within both the PRP group (n=27) and the placebo group (n=27), but there was no significant between-group difference (95% CI -1.6 to 7.8, p=0.169). After 6 weeks, the neovascularisation score increased within the PRP group (p=0.001) and the placebo group (p=0.002), but there was no significant between-group difference in change in neovascularisation score at any point in time. CONCLUSION: Injecting PRP for the treatment of chronic midportion Achilles tendinopathy does not contribute to an increased tendon structure or alter the degree of neovascularisation, compared with placebo. FUNDING: Biomet Biologics LLC, Warsaw, Indiana.
Authors: M Tohidnezhad; D Varoga; C J Wruck; L O Brandenburg; A Seekamp; M Shakibaei; T T Sönmez; Thomas Pufe; S Lippross Journal: Histochem Cell Biol Date: 2011-04-08 Impact factor: 4.304
Authors: Benjamin Dallaudière; Marta Lempicki; Lionel Pesquer; Liliane Louedec; Pierre Marie Preux; Philippe Meyer; Vincent Hummel; Ahmed Larbi; Lydia Deschamps; Clement Journe; Agathe Hess; Alain Silvestre; Paul Sargos; Philippe Loriaut; Patrick Boyer; Elisabeth Schouman-Claeys; Jean Baptiste Michel; Jean Michel Serfaty Journal: Eur Radiol Date: 2013-06-26 Impact factor: 5.315